Appointment booking for Dr. Rafael Hasbun, MD is currently not available.Dr. Rafael Hasbun, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Rafael Hasbun, MD (he/him) is a Internist in Marlton, NJ with over 18 years of experience. What is your opinion of Dr. Rafael Hasbun, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Rafael Hasbun, MD has received over $2,928 which includes payments from the following companies:
$592.85 from GlaxoSmithKline, LLC.
$442.88 from AstraZeneca Pharmaceuticals LP
$363.44 from Novo Nordisk Inc
$278.80 from Daiichi Sankyo Inc.
$151.41 from Takeda Pharmaceuticals America, Inc.
$116.04 from Amgen Inc.
$112.99 from Pfizer Inc.
$92.82 from Supernus Pharmaceuticals, Inc.
$82.41 from UCB, Inc.
$82.28 from Purdue Pharma L.P.
$68.65 from Horizon Pharma plc
$67.90 from sanofi-aventis U.S. LLC
$67.16 from Janssen Pharmaceuticals, Inc
$64.14 from Eisai Inc.
$38.65 from AbbVie, Inc.
$36.37 from Amarin Pharma Inc.
$34.20 from Boehringer Ingelheim Pharmaceuticals, Inc.
$29.55 from Horizon Pharma USA, Inc.
$29.18 from Endo Pharmaceuticals Inc.
$24.56 from Abbott Laboratories
Payments received by Dr. Rafael Hasbun, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!